Condition
Malignant Female Reproductive System Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Malignant Female Reproductive System Neoplasm clinical trials that are recruiting, at sites in 2 countries (most in United States (11), Puerto Rico (2)). By phase: Phase 2 (4), Phase 4 (1), Phase 1 (1). The most active sponsors are Mayo Clinic (3), National Cancer Institute (NCI) (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 2Countries
Newest Malignant Female Reproductive System Neoplasm clinical trials
All recruiting trials (11)
-
Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression
This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.
-
Feasibility of using SmartMatch for guiding treatment options in rare gynecologic cancers
This observational study tests whether SmartMatch analysis on tissue from standard surgeries or biopsies can help identify treatment options for adults with advanced rare gynecologic cancers.
-
Vaginal DHEA to improve vaginal health after pelvic radiation
This phase II trial tests whether daily vaginal DHEA can help reduce vaginal dryness, pain, and related symptoms in menopausal women after radiation for gynecologic, anal, or rectal cancers.
-
Using fucoidan to prevent fatigue in cancer patients undergoing chemotherapy
This study tests if a seaweed supplement called fucoidan can help cancer patients undergoing chemotherapy feel less tired.
-
Personalized online home walking program for women after gynecologic cancer
This trial will test whether a personalized online home walking program can help gynecologic cancer survivors reduce pain, fatigue, sleep problems, depression, cognitive difficulties, and alter gut bacteria.
-
Comparing methadone and hydromorphone for pain relief after gynecologic cancer surgery
This study is testing whether methadone can provide similar pain relief as hydromorphone for patients recovering from gynecologic cancer surgery.
-
Testing neratinib alone or with palbociclib for HER2 positive solid tumors
This study is testing if a new cancer treatment called neratinib works better alone or with another drug, palbociclib, for people with HER2 positive solid tumors, especially those with gynecologic cancers.
-
Understanding frailty in gynecologic cancer patients to improve recovery
This study looks at how frailty affects recovery and quality of life in adults newly diagnosed with gynecologic cancer to see what factors might contribute to being frail.
-
Targeted therapy for advanced solid tumors based on genetic testing
This study is testing whether matching patients with advanced solid tumors to specific treatments based on their genetic makeup can improve their outcomes when standard options have failed.
-
Genetic testing for cancer in diverse ethnic groups
This study is testing how genetic testing can help cancer patients from different ethnic backgrounds understand their risks and improve their personalized care.
-
Combining talazoparib with radiation therapy for recurrent gynecologic cancers
This study is testing if combining a drug called talazoparib with radiation therapy can safely help people with recurrent gynecologic cancers feel better.
Related topics
Quick answers
How many Malignant Female Reproductive System Neoplasm clinical trials are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (11 trials), Puerto Rico (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.